Amyris has announced that it has teamed up with an undisclosed partner in a US$255 million deal – its largest ever – to produce CBD from sugarcane using its fermentation technology.
If successful, the resulting CBD will boast significant advantages over that derived from cannabis, not least that it is cheaper, more consistent in terms of purity and dosage and natural sugarcane feedstock is said to be a more sustainable crop, requiring less water and land, relative to cannabinoids.
“We are pleased to have been recognized by a well-capitalized partner as the company best suited to leverage fermentation-based technology in the production of the best quality and lowest cost and sustainably-produced cannabinoids,” said John Melo, Amyris President & CEO. “The dollar value of this agreement and our roster of partners who are leaders in global markets combines to be a strong endorsement of our technology platform and ability to bring No Compromise™, sustainably-produced products to market. We share the mission of our partners to become the leader in sustainably-sourced CBD products in the near term as we focus on enabling the global beverage and skin care markets, including our own brands, to support the health and wellness of people and our planet.”